U.S. flag

An official website of the United States government

NM_000525.4(KCNJ11):c.152_158del (p.Glu51fs) AND Permanent neonatal diabetes mellitus

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jul 22, 2020
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001828735.1

Allele description [Variation Report for NM_000525.4(KCNJ11):c.152_158del (p.Glu51fs)]

NM_000525.4(KCNJ11):c.152_158del (p.Glu51fs)

Gene:
KCNJ11:potassium inwardly rectifying channel subfamily J member 11 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
11p15.1
Genomic location:
Preferred name:
NM_000525.4(KCNJ11):c.152_158del (p.Glu51fs)
HGVS:
  • NC_000011.10:g.17387937_17387943del
  • NG_012446.1:g.5720_5726del
  • NM_000525.4:c.152_158delMANE SELECT
  • NM_001166290.2:c.-16-94_-16-88del
  • NM_001377296.1:c.-17+78_-17+84del
  • NM_001377297.1:c.-16-94_-16-88del
  • NP_000516.3:p.Glu51fs
  • NC_000011.9:g.17409481_17409487del
  • NC_000011.9:g.17409484_17409490del
  • NM_000525.3:c.152_158del
Protein change:
E51fs
Links:
dbSNP: rs1953591118
NCBI 1000 Genomes Browser:
rs1953591118
Molecular consequence:
  • NM_000525.4:c.152_158del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001166290.2:c.-16-94_-16-88del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001377296.1:c.-17+78_-17+84del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001377297.1:c.-16-94_-16-88del - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Permanent neonatal diabetes mellitus (PNDM)
Synonyms:
Permanent diabetes mellitus of infancy
Identifiers:
MONDO: MONDO:0100164; MedGen: C1833104; OMIM: PS606176

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002085181Natera, Inc.
no assertion criteria provided
Likely pathogenic
(Jul 22, 2020)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002085181.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024